tetrabenazine has been researched along with Cognition Disorders in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 8 (88.89) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bohnen, JLB; Bohnen, NI; Haugen, J; Müller, MLTM | 1 |
Albin, RL; Bohnen, NI; Frey, KA; Koeppe, RA; Kotagal, V; Müller, ML; Scott, PJ; Studenski, S | 1 |
Bohnen, NI; Chou, KL; Koeppe, RA; Lenhart, A | 1 |
Albin, RL; Bohnen, NI; Frey, KA; Koeppe, RA; Kotagal, V; Müller, ML; Petrou, M; Scott, PJ | 1 |
Boileau, I; Furukawa, Y; Houle, S; Kish, SJ; McCluskey, T; Tong, J | 1 |
Albin, RL; Bohnen, NI; Frey, KA; Koeppe, RA; Kotagal, V; Müller, ML; Petrou, M; Scott, PJ; Shah, N | 1 |
Albin, RL; Burke, JF; Frey, KA; Gilman, S; Giordani, B; Kilbourn, MR; Koeppe, RA | 1 |
Billette de Villemeur, T; Camuzat, A; Caubel, I; Chantot-Bastaraud, S; Charles, P; Devos, D; Doummar, D; Durr, A; Epaud, R; Goizet, C; Gras, D; Guillot, L; Héron, B; Jonard, L; Kemlin, I; Koht, J; Lion-François, L; Louha, M; Motte, J; Moutard, ML; Polak, M; Rodriguez, D; Roze, E; Sanlaville, D; Tallot, M; Vidailhet, M; Vuillaume, I | 1 |
Carr, JM; Frey, KA; Giordani, BJ; Huguelet, P; Kilbourn, MR; Koeppe, RA; Ohl, LE; Zubieta, JK | 1 |
9 other study(ies) available for tetrabenazine and Cognition Disorders
Article | Year |
---|---|
Mentally stimulating activities associate with better cognitive performance in Parkinson disease.
Topics: Aged; Aged, 80 and over; Carbon Isotopes; Cognition Disorders; Cognitive Behavioral Therapy; Female; Humans; Magnetic Resonance Imaging; Male; Mental Status and Dementia Tests; Middle Aged; Neuropsychological Tests; Parkinson Disease; Phosphinic Acids; Piperidines; Positron-Emission Tomography; Regression Analysis; Tetrabenazine | 2017 |
Gait speed in Parkinson disease correlates with cholinergic degeneration.
Topics: Acetylcholinesterase; Aged; Aged, 80 and over; Analysis of Variance; Carbon Isotopes; Cerebral Cortex; Cognition Disorders; Cross-Sectional Studies; Dioxolanes; Female; Gait Disorders, Neurologic; Humans; Male; Middle Aged; Nerve Degeneration; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2013 |
Abnormal MoCA and normal range MMSE scores in Parkinson disease without dementia: cognitive and neurochemical correlates.
Topics: Acetylcholinesterase; Aged; Aged, 80 and over; Brain; Cognition Disorders; Female; Guanidines; Humans; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2014 |
Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease.
Topics: Aged; Butyrates; Carbon Isotopes; Cognition Disorders; Cross-Sectional Studies; Diabetes Complications; Diabetes Mellitus; Female; Humans; Male; Middle Aged; Neuroimaging; Neuropsychological Tests; Parkinson Disease; Piperidines; Positron-Emission Tomography; Severity of Illness Index; Tetrabenazine | 2014 |
Rapid Recovery of Vesicular Dopamine Levels in Methamphetamine Users in Early Abstinence.
Topics: Adult; Amphetamine-Related Disorders; Carbon Radioisotopes; Cocaine; Cognition Disorders; Corpus Striatum; Dopamine; Female; Humans; Male; Methamphetamine; Positron-Emission Tomography; Synaptic Vesicles; Tetrabenazine; Young Adult | 2016 |
Striatal and Cortical β-Amyloidopathy and Cognition in Parkinson's Disease.
Topics: Aged; Aged, 80 and over; Amyloid beta-Peptides; Analysis of Variance; Aniline Compounds; Carbon Isotopes; Cerebral Cortex; Cognition Disorders; Corpus Striatum; Cross-Sectional Studies; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Tetrabenazine; Thiazoles | 2016 |
Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment.
Topics: Age of Onset; Aged; Aged, 80 and over; Binding, Competitive; Brain Mapping; Carbon Radioisotopes; Cerebral Cortex; Cerebrovascular Circulation; Cognition Disorders; Dementia; Early Diagnosis; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tetrabenazine | 2010 |
Benign hereditary chorea: phenotype, prognosis, therapeutic outcome and long term follow-up in a large series with new mutations in the TITF1/NKX2-1 gene.
Topics: Adrenergic Uptake Inhibitors; Adult; Age of Onset; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Chorea; Chromosome Disorders; Cognition Disorders; Congenital Hypothyroidism; DNA Mutational Analysis; Female; Follow-Up Studies; France; Genes, Dominant; Humans; Infant; Male; Mutation; Neuropsychological Tests; Nuclear Proteins; Phenotype; Prognosis; Protein Array Analysis; Respiratory Tract Diseases; Tetrabenazine; Thyroid Nuclear Factor 1; Transcription Factors; Treatment Outcome | 2012 |
High vesicular monoamine transporter binding in asymptomatic bipolar I disorder: sex differences and cognitive correlates.
Topics: Adult; Biomarkers; Bipolar Disorder; Brain Stem; Cognition Disorders; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Neuropeptides; Presynaptic Terminals; Sex Factors; Tetrabenazine; Thalamus; Tomography, Emission-Computed; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2000 |